CS Paper Radar

Cross-cohort TB classification using clinical data gathered in Uganda and South Africa

Joshua M. Jansen van Vüren, Devendra S. Parihar, Daphne Naidoo, Marisa Klopper, Frank Cobelens, Lutz Kolbe, Kimsey Zajac, Willy Ssengooba, Moses Joloba, Grant Theron, Thomas R. Niesler

cs.LG ·submitted 2026-10-02 13:01 UTC · v1
published

Abstract

We present a first evaluation of machine learning applied to patient clinical and demographic data gathered in two different countries for the purpose of tuberculosis (TB) screening to identify people who would benefit from expensive molecular testing. Experiments are based on the recently-compiled CAGE-TB dataset, which includes sub-cohorts of people with presumptive TB presenting at community health care centres in South Africa and Uganda. Three neural network architectures (logistic regression (LR), multilayer perceptrons (MLP) and convolutional neural networks (CNN)) are considered in conjunction with greedy feature selection. For the convolutional neural network, a strategy that jointly optimises feature selection and feature ordering is proposed and shown to lead to consistent development and test set improvements. For all three models, development set area under the receiver operating characteristic (AUROC) curve is improved by 2-7% using feature selection. LR after feature selection achieves an AUROC of 0.8 [0.75,0.86] (95% CI) and 0.84 [0.78,0.9] when testing on the held-out Ugandan and South African data respectively. Although outperforming LR on the development cohort, the deeper networks (MLP, CNN) show inconsistent trends on the held-out cohorts, while LR achieves performance within 1-2% of the best achieved in terms of AUROC. LR narrowly misses the WHO minimum requirements by 4-9% in sensitivity even though the network is being evaluated on a completely held-out cohort. The development of neural-network based classifiers for TB screening therefore appears viable.

Comment
Accepted: SATNAC, Drakensberg, South Africa, 2026

Closest papers

Nearest neighbours by meaning across the whole index.

How well do routinely collected demographic and clinical variables aid point-of-care lung ultrasound TB classification

eess.IV cs.CVcs.LG ·2026-10-05 ·Joshua M. Jansen van Vüren, Christiaan M. Geldenhuys, Devendra S. Parihar, Véronique Suttels, Trevor Brokowski +5 more
published similarity 0.73
Abstract · Accepted: SATNAC, Drakensberg, South Africa, 2026

We consider the fusion of lung ultrasound images with routinely-collected clinical and demographic data for the purpose of automated tuberculosis (TB) screening using deep-learning. Such deep-learning based screening tools for TB could meaningfully support the health care system in Africa, where the burden of disease is severe and resources are constrained. Beginning with an established ResNet baseline for classification of lung ultrasound images, which achieves an area under the receiver operating characteristic (AUROC) curve of 0.91 [0.86,0.96] (95% CI), we consider the incorporation of the clinical and demographic data using three fusion approaches. We find that a simple average-based fusion of the output scores of separately-trained image and clinical data classifiers consistently matches or outperforms a more complex approach where the data is fused earlier and a combined classifier is trained. Fusing the image and the clinical classifiers in this way leads to a classifier with an overall AUROC of 0.95 [0.91,0.99] (specificity of 0.76 at sensitivity 0.93) which is an improvement of 4% absolute over the image-only baseline. We also find that greedy feature selection can be used to reduce the number of clinical and demographic inputs without sacrificing classification performance. Finally, when we differentiate between clinical and demographic data that are self-reported, that require some basic measurement or calculation, and that require a point-of-care (POC) test, we find the inclusion of the POC tests included in this study to be of minimal benefit to classification performance. We conclude that the incorporation of routinely-collected clinical and demographic data is a promising way to improve the performance of lung ultrasound based automatic classification.

0.25

Why ML-based cough models do not generalize: a systematic cross-dataset evaluation for tuberculosis screening

eess.AS cs.AIcs.LGcs.SD+1 ·2026-08-26 ·Wensi Zhang, Tomas Teijeiro, Jérôme Thevenot, David Atienza
similarity 0.64
Abstract

Cough acoustics are promising for non-invasive tuberculosis (TB) screening, yet whether machine learning (ML) models capture disease-related acoustics or artifacts of data collection remains unresolved. We evaluated the cross-dataset generalizability of classical ML and deep learning (DL) cough-based TB classifiers across three independent datasets. Despite moderate within-dataset performance (ROC-AUC up to $0.755 \pm 0.056$), both pipelines fail to generalize, with external performance frequently below 0.6, indicating a possible limitation of the data. We further observed audio representations are organized by recording device and dataset rather than TB status, predicted TB probability tracks country-level prevalence in CODA, and device mismatch degrades transfer while device-diverse training improves it. Additionally, a clinical-variable baseline generalizes more consistently (ROC-AUC $0.655 - 0.711$), indicating acquisition-specific variability is a stronger driver of poor generalizability than population shift. High within-dataset performance is not enough. External validation is essential before cough-based TB models are clinically ready.

0.07

Towards Transparent Diagnostics: Investigating Architectural Trade-offs and Explainability in Malaria Detection

cs.CV ·2026-09-16 ·Suman Kunwar, Avishek Dangol
similarity 0.62
Abstract · 14 pages, 10 figures

More than 80 countries have reported malaria cases with 610 thousand deaths and are projected to increase. Identifying malaria early and accurately helps save lives and effective way to diagnose malaria is through microscopic methods that are labor intensive and require experts with special equipment. Deep learning (DL) has shown promising results in medical diagnosis. Here, we explored various DL models: ResNet18, MobileNetV2, EfficientNet-B2, VGG19 and proposed model ResNet18+TTA (ResNet18 backbone with modified classification head and test time augmentation) for detecting malaria presence using blood smears taken from the NIH Malaria dataset. Our experiment shows MobileNetV2 achieved 96.85 % accuracy with smallest model size (8.49 MB) and fastest inference (1.35 ms). The ResNet18+TTA model achieved 97.96 % accuracy, 0.996 AUC with longest inference time (13.32 ms). Larger architecture outputs a larger model size with moderate accuracy. Upon further pruning, ResNet18+TTA model gained a slight improvement in accuracy and reduced inference time. GRAD-CAM, SHAP and LIME provide explainable AI (XAI) insights into model predictions, using explanation agreement and divergence to evaluate predictive reliability.

0.19

EMFE: A lightweight, explainable machine learning framework for malaria cell classification

cs.CV ·2026-08-25 ·Md Abdullah Al Kafi, Walayat Hussain, Mousumi Karmakar, Sumit Kumar Banshal, Ahmed Al Marouf
similarity 0.61
Abstract

Automated malaria diagnosis from stained blood-smear microscopy is dominated by deep convolutional neural networks that are accurate but computationally expensive, poorly interpretable, and rarely validated with patient-level rigor. We present EMFE (Efficient Mathematical Feature Extraction), a five-feature framework for classifying single red-blood-cell images as parasitized or uninfected using Gray World color normalization, adaptive green-channel thresholding, morphological spot detection, and classical machine learning. Using the NIH LHNCBC malaria dataset (27,558 images from 200 patients), we evaluate Random Forest, Histogram Gradient Boosting, and Support Vector Machine classifiers under patient-grouped nested cross-validation (K_outer=20, K_inner=3), ensuring that cells from each patient remain within a single fold. The optimized Random Forest achieves 94.6% pooled out-of-fold accuracy (95% CI [93.6, 95.7]), corroborated by an untouched 40-patient holdout test (94.3%) and a patient-level permutation test (p<0.001, 1,000 permutations). Ablation experiments quantify the contribution of individual features and pipeline stages. Hardware-matched comparisons with retrained DenseNet121, ResNet50, and MobileNetV2 models assess the accuracy-efficiency trade-off. Synthetic perturbations characterize three failure modes, while explainability analysis identifies spot saturation as the dominant discriminative feature. Patient-level aggregation further quantifies sensitivity-specificity trade-offs and false-positive accumulation. These results demonstrate a statistically rigorous, interpretable, and computationally lightweight alternative to deep learning, while explicitly quantifying its limitations.

0.24

Parallel Training Using a CNN-DNN Architecture for Accelerated Development of Diagnostic Models

cs.CV ·2026-09-11 ·Janine Weber-Hamacher, Astha Jaiswal, Philipp Fervers, Dorotya Móré, Athanasios Giannakis +6 more
similarity 0.59
Abstract

Artificial intelligence has shown promise in assisting radiologists in imaging-based diagnosis across a wide range of diseases. Efficient training of large deep learning models is essential to cope with extremely large data sets or dynamically growing disease data, like in a pandemic like situation. In this retrospective study, we collected 300 CT scans from COVID-19 and non-COVID-19 pneumonia patients from three different centers in Germany. We investigated a hybrid CNN-DNN network model based on image decomposition and localization that naturally supports parallel and efficient training of deep learning models. In total, 156 models with three different architectures were trained to capture features at different levels resulting in 12 patient-level COVID-19 diagnosis models. Diagnostic performance as well as time saving were measured. The highest accuracy was obtained from DenseNet121 and 3D CNN models with a parallel CNN-DNN approach, resulting in $88.78\%$ training, $76.67\%$ validation and $76.03\%$ test accuracy for the DenseNet121 with $4\times4\times1$ subdomains and $87.72\%$ training, $76.82\%$ validation and $74.86\%$ test accuracy, respectively, for the 3D CNN with $4\times4\times1$ subdomains. The strongest reduction in parallel training time by a factor of $31$ was observed for the 3D CNN model and $4\times4\times2$ subdomains. Our parallel training approach improves efficiency as well as performance enabling rapid model development, among others crucial for pandemic preparedness.

0.27

Beyond Benchmark Scores: Auditing Medical Vision-Language Models for Chest X-Ray Tuberculosis Screening

cs.CV cs.LG ·2026-09-18 ·Mushir Akhtar, M. Tanveer, Mohd. Arshad
benchmark similarity 0.58
Abstract · 27 pages, 7 figures, and 21 tables; includes extended methods, statistical analyses, and robustness evaluations

A medical model's benchmark score does not establish that the same conclusion holds under a different evaluation. This study tests whether claims about model ranking, score reliability and screening performance survive changes in cohort, prompt, negative spectrum, specified prevalence and operating threshold. We audit three medical vision-language models (BioMedCLIP, CheXficient, and MedSigLIP) and a general-domain OpenCLIP comparator on 12,200 chest radiograph records from four datasets (Montgomery, Shenzhen, TBX11K, and VinDr-CXR). Five fixed prompt families yield 244,000 model--image--prompt scores. No model leads every cohort and reliability criterion. Prompt-family changes alter AUROC in 21 of 48 multiplicity-controlled comparisons. Replacing healthy controls with sick non-tuberculosis controls reduces AUROC by 0.075--0.306 across all four models. On VinDr-CXR, the three medical models distinguish tuberculosis from no-finding controls substantially better than from pneumonia or lung tumor; their AUROC point estimates for both named diseases fall below 0.5. CheXficient has documented VinDr-CXR pretraining exposure, which limits the interpretation of its results. Thresholds chosen for 95\% sensitivity on TBX11K training retain that constraint by point estimate in only four of sixteen target evaluations. A five-seed supervised source model reaches 0.999 AUROC on TBX11K validation but 0.629 on each of two external cohorts. Conservative exclusion of perceptual-overlap candidates narrows this gap without closing it. These retrospective, single-task results show that discrimination, score reliability and threshold retention support different portability claims. Evidence for chest X-ray tuberculosis screening should identify the complete evaluation specification rather than attribute clinical portability to a checkpoint alone.

0.28

Few-Shot Cross-Dataset Adaptation for Tuberculosis Detection Using DenseNet

cs.CV ·2026-08-16 ·Bidhan Biswas, Shahadat Hossain Sohag, Nabil Ashab, Soumit Kumar Kundu, Saif Mahmud Parvez
similarity 0.58
Abstract

Tuberculosis (TB) is one of the most common and dangerous bacterial ailments. Every year, it causes a large number of deaths worldwide. Although many deep learning models can detect tuberculosis from chest X-rays quite accurately, severe domain shift across datasets makes the task challenging. Different imaging protocols, patient demographics, and equipment across domains make the task of generalization difficult. In real-world settings, a model may perform well on one dataset but show a noticeable drop in performance when tested on another. In this work, we address this domain adaptation challenge through a few-shot scaling study. A controlled cross-dataset evaluation is presented in this paper using TBX11K as the source domain and the Mendeley TB dataset as the target domain. It is investigated how varying the number of target samples affects model performance under three training regimes: frozen backbone adaptation, full fine-tuning of a source-pretrained DenseNet121 model, and training from scratch. The results indicate that the model can perform well even with limited data and can achieve 98.36\% accuracy with just 75 labeled samples per class. The adaptation curves demonstrate how fine-tuning effectively mitigates domain shift. These findings establish full fine-tuning of pretrained models as a highly effective and practical strategy for mitigating domain shift in low-resource clinical deployment scenarios.

0.04

Deep-Learning Algorithm for Indeterminate Thyroid Nodules: Comparison and Combination with Molecular Testing

cs.CV q-bio.QMeess.IV ·2026-10-16 ·Jichen Yang, Jeffrey Ashton, Jikai Zhang, Maciej A. Mazurowski, Benjamin Wildman-Tobriner
similarity 0.58
Abstract · 16 pages, 7 figures, 8 tables (3 supplementary)

Thyroid nodules with indeterminate cytology (Bethesda III) carry an intermediate risk of malignancy, and molecular testing is widely used to decide between surgery and surveillance, but it is costly and not universally available. We investigated whether a convolutional neural network (CNN) applied to routine ultrasound images can stratify Bethesda III nodules, and how it compares and combines with molecular testing. We retrospectively identified 466 nodule records from 418 patients who underwent molecular testing (Afirma or ThyroSeq). A CNN pre-trained on determinate nodules was adapted to indeterminate nodules with soft labels and transfer learning. After removal of duplicate records, 119 nodules with surgical pathology were used for development and 47 were held out for testing. On the test set, the deep learning (DL) model achieved an AUC of 0.73 (95% CI 0.51-0.94), compared with 0.55 (0.38-0.71) for molecular testing (P = 0.15). At a cut-off inherited from the original algorithm, the DL model was more specific than molecular testing (0.95 vs 0.32; P < 0.001), with a higher positive predictive value (0.67 vs 0.21), a lower sensitivity (0.44 vs 0.78; P = 0.25) and a similar negative predictive value (0.88 vs 0.86). All six DL-positive test nodules were molecular-positive, and the DL output split the molecular-positive nodules into a high-risk (4/6 malignant) and a lower-risk group (3/27 malignant; P = 0.01). Surgical verification was strongly driven by the molecular result (99% of positive vs 19% of negative results), and molecular-test accuracy depended on the platform. A logistic regression of the DL output, nodule size and the molecular result dropped the DL term and did not improve on the DL output alone. Ultrasound DL complemented molecular testing for Bethesda III nodules, in particular by identifying molecular-positive nodules at lower risk of malignancy.

0.14